Skip to content
OpenCapital
Get started

Vaxcyte, Inc. PCVX Market capitalization

Market capitalization at other companies

Pfizer logo
PfizerPFE
$159.73B+11.1%
Merck & Co. logo
Merck & Co.MRK
$297.4B+31.2%
Moderna logo
ModernaMRNA
$20.15B+83.8%
Krystal Biotech, Inc. logo
Krystal Biotech, Inc.KRYS
$7.55B+45.4%
ImmunityBio, Inc. logo
ImmunityBio, Inc.IBRX
$7.92B+208%
Vertex Pharmaceuticals logo
Vertex PharmaceuticalsVRTX
$113.44B-8.9%

Other financials

Income statement

See full
Operating income-$345.9M-91.3%
Net income-$320.6M-128%
EPS (diluted)-$2.30-121%

Balance sheet

See full
Cash & equivalents$262.3M-24.7%
Total debt$116.3M+33.5%
Total equity$3.0B-6.4%
Total assets$3.3B-0.9%

Cash flow

See full
Operating cash flow-$280.6M-68.8%
CapEx$2.1M-61.2%
Free cash flow-$282.7M-64.7%

Valuation

See full
Enterprise value$7.28B+78.6%

Returns & leverage

See full
Return on equity-30.6%+37.9pp
Debt / equity0×0.0×
Current ratio7.5×-10.2×

Where this comes from

Computed from the period-end share price: $8.36B.

The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Vaxcyte, Inc.'s market capitalization.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Vaxcyte, Inc.'s market capitalization?
Vaxcyte, Inc. (PCVX) reported market capitalization of $8.36B in Q1 2026.
How has Vaxcyte, Inc.'s market capitalization changed year-over-year?
Vaxcyte, Inc.'s market capitalization increased by 72.0% year-over-year, from $4.86B to $8.36B.
What is the long-term trend for Vaxcyte, Inc.'s market capitalization?
Over 5 years (2020 to 2025), Vaxcyte, Inc.'s market capitalization has grown at a 34.7% compound annual growth rate (CAGR), from $1.36B to $6.04B.
What does market capitalization mean?
The total market value of the company's equity at the quarter end (share price × shares outstanding), sampled from daily market data. The latest point tracks the live price.